BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nath H, Mallick A, Roy S, Sukla S, Biswas S. Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity? Comput Struct Biotechnol J 2021;19:459-66. [PMID: 33391633 DOI: 10.1016/j.csbj.2020.12.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Islam A, Cockcroft C, Elshazly S, Ahmed J, Joyce K, Mahfuz H, Islam T, Rashid H, Laher I. Coagulopathy of Dengue and COVID-19: Clinical Considerations. TropicalMed 2022;7:210. [DOI: 10.3390/tropicalmed7090210] [Reference Citation Analysis]
2 Cheng Y, Chao C, Lai Y, Hsieh K, Wang J, Wan S, Huang H, Chuang Y, Chuang W, Yeh T. Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis. Front Immunol 2022;13:941923. [DOI: 10.3389/fimmu.2022.941923] [Reference Citation Analysis]
3 Thangamani N, Velmurugan LS, Varadarajan P, Shanmugam S, Ravindran A. COVID-19 Antibody Status and Its Impact on the Severity of Dengue Fever among Children: An Observational Study. Indian J Pediatr 2022. [PMID: 35854098 DOI: 10.1007/s12098-022-04266-1] [Reference Citation Analysis]
4 Luvira V, Leaungwutiwong P, Thippornchai N, Thawornkuno C, Chatchen S, Chancharoenthana W, Tandhavanant S, Muangnoicharoen S, Piyaphanee W, Chantratita N. False Positivity of Anti-SARS-CoV-2 Antibodies in Patients with Acute Tropical Diseases in Thailand. TropicalMed 2022;7:132. [DOI: 10.3390/tropicalmed7070132] [Reference Citation Analysis]
5 Nath H, Mallick A, Roy S, Kayal T, Ranjan S, Sengupta S, Sukla S, Biswas S. COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test. Int J Infect Dis 2022;122:576-84. [PMID: 35811081 DOI: 10.1016/j.ijid.2022.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yong YK, Wong WF, Vignesh R, Chattopadhyay I, Velu V, Tan HY, Zhang Y, Larsson M, Shankar EM. Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19. Front Immunol 2022;13:889196. [DOI: 10.3389/fimmu.2022.889196] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gao K, Wang R, Chen J, Cheng L, Frishcosy J, Huzumi Y, Qiu Y, Schluckbier T, Wei X, Wei GW. Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chem Rev 2022. [PMID: 35594413 DOI: 10.1021/acs.chemrev.1c00965] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gupta S, Arora S, Gupta M, Jesrani G. Dengue Myocarditis Complicated by COVID-19: A Case Report on Dual Viral Infection. Cureus 2021;13:e17076. [PMID: 34522553 DOI: 10.7759/cureus.17076] [Reference Citation Analysis]
9 Mallano A, Ascione A, Flego M. Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development. Int Rev Immunol 2021;:1-21. [PMID: 34494500 DOI: 10.1080/08830185.2021.1929205] [Reference Citation Analysis]
10 Ferreira MU, Nicolete VC, Castro MC. Reply to Author. Clin Infect Dis 2021:ciab621. [PMID: 34240139 DOI: 10.1093/cid/ciab621] [Reference Citation Analysis]
11 Nath H, Mallick A, Roy S, Sukla S, Basu K, De A, Biswas S. Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests. J Med Microbiol 2021;70. [PMID: 34110279 DOI: 10.1099/jmm.0.001369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
12 Villamil-Gómez WE, Rojas-Torres I, Perea-Vásquez LE, Collazos-Torres LA, Murillo-Moreno MA, Morales-Rudas JD, Pagani N, Rodriguez-Morales AJ, Paniz-Mondolfi AE. SARS-CoV-2 and Dengue virus co-infection: A case from North Caribbean Colombia. Travel Med Infect Dis 2021;43:102096. [PMID: 34091012 DOI: 10.1016/j.tmaid.2021.102096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Lytton SD, Yeasmin M, Ghosh AK, Bulbul MRH, Molla MMA, Herr M, Duchmann H, Sharif MM, Nafisa T, Amin MR, Hosen N, Rahman MT, Islam S, Islam A, Shamsuzzaman AKM. Detection of Anti-Nucleocapsid Antibody in COVID-19 Patients in Bangladesh Is not Correlated with Previous Dengue Infection. Pathogens 2021;10:637. [PMID: 34067281 DOI: 10.3390/pathogens10060637] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Nicolete VC, Rodrigues PT, Johansen IC, Corder RM, Tonini J, Cardoso MA, de Jesus JG, Claro IM, Faria NR, Sabino EC, Castro MC, Ferreira MU. Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated with Increased COVID-19 Risk in a Population-Based Cohort Study. Clin Infect Dis 2021:ciab410. [PMID: 33956939 DOI: 10.1093/cid/ciab410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Biswas S, Sukla S, Roy S, Nath H, Mallick A. Regarding: Masyeni S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, Nainu F, Harapan H, et al. Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis 2020;102:152-4. https://doi.org/10.1016/j.ijid.2020.10.043. Int J Infect Dis 2021;104:737-8. [PMID: 33556608 DOI: 10.1016/j.ijid.2021.01.063] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Papadimos TJ, Soghoian SE, Nanayakkara P, Singh S, Miller AC, Saddikuti V, Jayatilleke AU, Dubhashi SP, Firstenberg MS, Dutta V, Chauhan V, Sharma P, Galwankar SC, Garg M, Taylor N, Stawicki SP. COVID-19 Blind Spots: A Consensus Statement on the Importance of Competent Political Leadership and the Need for Public Health Cognizance. J Glob Infect Dis 2020;12:167-90. [PMID: 33888955 DOI: 10.4103/jgid.jgid_397_20] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]